Unlabelled: Hughes-Stovin syndrome is a very rare condition with no defined diagnostic criteria. We present the case of a 26-year-old man who had haemoptysis revealing Hughes-Stovin syndrome. We will consider the aetiology, therapeutic and evolutionary aspects of this disease.
Learning Points: Hughes-Stovin syndrome is a very rare disorder of unknown aetiology which can be fatal.It is considered a variant of Behcet's disease.Early diagnosis and treatment improve prognosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592656 | PMC |
| http://dx.doi.org/10.12890/2021_002810 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare cause of recurrent massive hemoptysis.
Respirol Case Rep
December 2024
Department of Pulmonary Medicine St. John's National Academy of Health Sciences Bengaluru India.
Pulmonary artery aneurysmal rupture is a rare cause of massive hemoptysis. When the suspected origin of bleeding is the pulmonary artery, comprehensive evaluation is necessary to determine aetiology and guide appropriate management. Behçet's disease and Hughes-Stovin Syndrome (HSS) are important differentials to consider after infections and malignancy have been ruled out.
View Article and Find Full Text PDFDeep vein thrombosis and aneurysm co-occurrence: a case report and review of the literature.
J Med Case Rep
December 2024
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Article Synopsis
- A rare case report discusses a 20-year-old Iranian woman who experienced a ruptured right common iliac aneurysm one year after having deep vein thrombosis (DVT), which was treated with rivaroxaban.
- The surgical repair was successful, but she faced complications, including abdominal pain, small bowel obstruction, and a large pancreatic pseudocyst, despite ongoing anticoagulant therapy.
- The report highlights the unusual link between DVT and vascular aneurysms and emphasizes the need to consider potential complications arising from aneurysms when treating DVT in patients.
A Rare Case of Pulmonary Artery Trunk Aneurysm.
Vasc Endovascular Surg
February 2025
Nuclear and Energy Research Institute (IPEN), University of São Paulo, São Paulo, SP, Brazil.
Background: Pulmonary artery trunk aneurysm (PATA) is a rare and complex vascular anomaly characterized by the abnormal dilation of the initial portion of the pulmonary artery, posing significant diagnostic and therapeutic challenges.
Purpose: This clinical case report aims to describe the follow-up of a patient with PATA, emphasizing the role of imaging in diagnosis and monitoring, as well as discussing potential associations with other conditions.
Research Design: The study is designed as a clinical case report, detailing the longitudinal follow-up of a single patient with PATA.
Behçet's Syndrome With Multiple Bilateral Pulmonary Aneurysms Associated With Endomyocardial Fibrosis Presented With Pulmonary Emboli: A Case Report.
Cureus
August 2024
Department of Diagnostic Radiology, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Munawwarah, SAU.
Behçet's syndrome (BS) is a rare chronic multisystemic inflammatory disorder of unknown etiopathogenesis. BS is classified as a vasculitis of variable vessel size, which can manifest in both arterial and venous blood vessels. BS commonly presents with mucocutaneous and ocular manifestations.
View Article and Find Full Text PDFBeyond the ordinary: TNF-alpha inhibitor as a rescue therapy in relapsing Hughes-Stovin syndrome with intracardiac thrombosis-a case report and literature review.
Eur Heart J Case Rep
August 2024
Internal Medicine Department, Ibn Sina University Hospital, Mohammed V University, 10100 Rabat, Morocco.
Article Synopsis
- * A case study describes a 28-year-old man who experienced symptoms like coughing up blood and chest pain, along with complications seen via imaging, initially managed with high-dose corticosteroids and other immunosuppressants.
- * The patient's condition relapsed after 18 months, but treatment with infliximab (a TNF-alpha inhibitor) led to complete remission, suggesting its potential as an effective second-line therapy for relapsing HSS cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!